EM1602G "Management of Advanced Hepatocellular Carcinoma" (IM GR020516)
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Understand the challenges and goals of systemic therapy for HCC.
- Understand the history of clinical trials in advanced HCC.
- Define the standard of care for advanced, unresectable HCC.
- Overview of failed therapies tested in Phase 3 trials.
Hao Zhu, M.D.
Children’s Medical Center Research Institute and Pediatrics
Division of Hematology and Oncology
- 1.00 AMA